Chemotherapy News

HealthDay - MONDAY, Nov. 19 (HealthDay News) -- A non-toxic, non-psychoactive compound in marijuana may block the progress of metastatic breast cancer, according to a new study by researchers in California.

American Cancer Society - There's good news for advanced breast cancer patients who haven't responded to current chemotherapy drugs.

HealthDay - FRIDAY, Nov. 16 (HealthDay News) -- U.S. researchers believe they're on the way to solving a major question about breast cancer: Which women have a type of lesion in their breast duct that will progress to invasive disease?

HealthDay - WEDNESDAY, Nov. 14 (HealthDay News) -- A highly targeted biologic drug called cetuximab (Erbitux) is the first to extend the survival of patients with advanced colon cancer who have otherwise proved resistant to conventional chemotherapy, Canadian researchers confirmed.

Reuters - Among postmenopausal women receiving adjuvant therapy for early breast cancer, exemestane is associated with fewer hot flashes than is tamoxifen, but it also causes more sleep problems, according to a study published the Journal of Clinical Oncology.

HealthDay - TUESDAY, Nov. 13 (HealthDay News) -- A new study is questioning the conventional wisdom of checking on the health of 12 lymph nodes after colon cancer surgery.

AP - The Food and Drug Administration called on physicians Thursday to warn cancer patients undergoing chemotherapy that certain anti-anemia drugs led to tumor growth and decreased survival in some patients.

AFP - Researchers have identified a new target for drugs to help treat the most common form of breast cancer in the developing world, a study released Thursday said.

Reuters - Amgen Inc said on Thursday it has strengthened the warnings on its anemia drug Aranesp and six new clinical trials have been designed to assess the safety of such drugs when used to treat chemotherapy-induced anemia in specific tumor types.

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Reuters - Drugmaker Novacea Inc ended a late-stage trial of its prostate cancer drug Asentar, after a treatment arm containing the drug showed a higher death rate compared with the standard care, driving shares down more than 69 percent to a lifetime low.

HealthDay - WEDNESDAY, Oct. 31 (HealthDay News) -- Treatment of stomach cancer with an experimental chemotherapy drug after surgery improved survival rates for Japanese patients, a new study found.

HealthDay - SUNDAY, Oct. 28 (HealthDay News) -- Ovarian cancer has long had a reputation as a silent killer, because many people believed it gave no warning signs until far advanced.

HealthDay - WEDNESDAY, Oct. 24 (HealthDay News) -- The addition of the chemotherapy drug, docetaxel, to the standard two-drug regimen used for head and neck cancers improved the efficacy of the treatment while reducing the toxicity, two new studies report.

The addition of the chemotherapy drug, docetaxel, to the standard two-drug regimen used for head and neck cancers improved the efficacy of the treatment while reducing the toxicity, two new studies report.

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

AP - More women who have cancer in only one breast are getting both breasts removed, says research that found the trend more than doubled in just six years. It's still a rare option: Most breast cancer in this country is treated by lumpectomy, removing just the tumor while saving the breast.

Reuters - Doctors treating cancer patients should try harder to help them deal with the emotional toll the disease exacts, an expert panel said on Tuesday.

HealthDay - SUNDAY, Oct. 21 (HealthDay News) -- As women live longer lives, the number of breast cancer cases among older patients is rising, too.

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch: